Thorkelsdottir Thordis, Johannesdottir Hera, Arnadottir Linda Osk, Adalsteinsson Jonas, Gardarsdottir Helga Run, Helgason Dadi, Axelsson Tomas Andri, Helgadottir Solveig, Heimisdottir Alexandra Aldis, Sigurdsson Martin Ingi, Gudbjartsson Tomas
Faculty of Medicine, University of Iceland, Departments.
Departments of Cardiothoracic Surgery.
Laeknabladid. 2019;105(7):319-326. doi: 10.17992/lbl.2019.0708.240.
Our objective was to investigate long-term outcomes of obese patients undergoing coronary artery bypass grafting (CABG) in Iceland.
A retrospective analysis on 1698 patients that underwent isolated CABG in Iceland between 2001-2013. Patients were divided into four groups according to body mass index (BMI); Normal=18.5-24.9kg/m2 (n=393), ii) overweight=25-29.9 kg/m2 (n=811), iii) obese=30-34.9 kg/m2 (n=388) and iv) severely obese ≥35kg/m2 (n=113). Thirty-day mortality and short-term complications were documented as well as long-term complications that were pooled into major adverse cardiac and cerebrovascular events (MACCE) and included myocardial infarction, stroke, repeated CABG, percutaneous coronary intervention with or without stenting, and death. After pooling the study groups, survival and freedom from MACCE plots (Kaplan- Meier) were generated and Cox regression analysis used to identify predictive factors of survival. Average follow-up time was 5.6 years.
Severely obese and obese patients were significantly younger than those with a normal BMI, more often males with identifiable risk factors of coronary artery disease (CAD) and a lower EuroSCORE II (1.6 vs. 2.7, p=0.002). The incidence of major early complications, 30-day mortality (2%), long-term survival (90% at 5 years, log-rank test p=0.088) and MACCE-free survival (81% at 5 years, log-rank test p=0.7) was similar for obese and non-obese patients. BMI was neither an independent predictor for long-term (OR: 0.98 95%-CI: 0.95-1.01) nor MACCE-free survival (OR: 1.0 95%-CI: 0.98-1.02). Conclusions: Obese patients that undergo CABG in Iceland are younger and have an increased number of risk factors for coronary disease when compared to non-obese patients. However, BMI neither predicted long-term survival or long-term complications. The outcomes following CABG in obese patients are good in Iceland.
我们的目的是调查冰岛接受冠状动脉旁路移植术(CABG)的肥胖患者的长期预后。
对2001年至2013年期间在冰岛接受单纯CABG的1698例患者进行回顾性分析。根据体重指数(BMI)将患者分为四组:i)正常=18.5-24.9kg/m²(n=393),ii)超重=25-29.9kg/m²(n=811),iii)肥胖=30-34.9kg/m²(n=388),iv)重度肥胖≥35kg/m²(n=113)。记录30天死亡率和短期并发症以及长期并发症,这些并发症汇总为主要不良心脑血管事件(MACCE),包括心肌梗死、中风、再次CABG、有或无支架置入的经皮冠状动脉介入治疗以及死亡。合并研究组后,生成生存和无MACCE事件的生存曲线(Kaplan-Meier),并使用Cox回归分析确定生存的预测因素。平均随访时间为5.6年。
重度肥胖和肥胖患者比BMI正常的患者明显年轻,男性更多,有可识别的冠状动脉疾病(CAD)危险因素,且欧洲心脏手术风险评估系统II(EuroSCORE II)较低(1.6对2.7,p=0.002)。肥胖和非肥胖患者的主要早期并发症发生率、30天死亡率(2%)、长期生存率(5年时为90%,对数秩检验p=0.088)和无MACCE事件生存率(5年时为81%,对数秩检验p=0.7)相似。BMI既不是长期生存(比值比:0.98,95%置信区间:0.95-1.01)的独立预测因素,也不是无MACCE事件生存(比值比:1.0,95%置信区间:0.98-1.02)的独立预测因素。结论:与非肥胖患者相比,在冰岛接受CABG的肥胖患者更年轻,冠状动脉疾病的危险因素数量更多。然而,BMI既不能预测长期生存也不能预测长期并发症。在冰岛,肥胖患者接受CABG后的预后良好。